![]() |
市场调查报告书
商品编码
1904587
消化健康食品和益生菌快速消费品市场预测至2032年:按产品类型、分销管道、技术和地区分類的全球分析Digestive Health Foods & Probiotic FMCG Market Forecasts to 2032 - Global Analysis By Product Type, Distribution Channel, Technology and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球消化健康食品和益生菌快速消费品市场价值将达到 560.9 亿美元,到 2032 年将达到 980.2 亿美元,在预测期内的复合年增长率为 8.3%。
消化健康食品和益生菌快速消费品旨在改善消化功能并维持健康的肠道菌丛。这些产品包括益生菌、发酵食品、益生元强化点心和机能饮料,它们都能促进有益肠道细菌的生长。健康意识的提高、消化问题发病率的增加以及人们对预防性健康解决方案的日益重视,正在推动市场成长。这些产品可透过超级市场、药局和线上平台购买,吸引那些寻求天然、经科学验证的方法来改善消化健康和整体健康的消费者。
胃肠道疾病呈上升趋势
饮食习惯的改变、高压力水平、久坐的生活方式以及加工食品消费量的增加,正在加剧全球范围内的肠道相关问题。消费者越来越倾向于寻求预防性和日常营养的解决方案,而非只依赖治疗方法。益生菌和消化健康食品被认为是恢復肠道菌丛平衡和改善整体消化功能的有效选择。人们对肠脑轴和肠免疫轴之间联繫的认识不断提高,进一步推动了市场渗透。医疗保健专业人员也推荐益生菌作为维护消化健康的辅助。人们对消化健康的持续关注是成长要素。
缺乏全球标准化
益生菌、益生元和后生元的监管定义在不同地区差异显着,为生产者带来了合规的复杂性。菌株检验、剂量水平和健康声明等方面的要求不一致,限制了产品的全球规模化生产。企业必须与包括FDA、EFSA和FSSAI在内的多个食品安全监管机构打交道,而每个机构都有各自的核准流程。由于研发能力有限,小规模公司往往难以满足科学论证的要求。这种监管上的碎片化增加了产品上市时间和营运成本。因此,缺乏标准化阻碍了创新和跨境市场扩张。
非乳製品和植物来源创新
乳糖不耐症的日益普遍、素食生活方式的兴起以及乳製品过敏的流行,正促使消费者寻求益生菌的替代来源。製造商们正不断创新,推出植物来源产品,例如发酵果汁、谷物、豆类、康普茶和植物优格。这些产品吸引了注重健康和环保、追求「洁净标示」解决方案的消费者。发酵技术的进步正在提高益生菌在非乳製品基质中的稳定性和功效。品牌正在利用超级食品和功能性植物成分来增强消化益处。这种向植物来源创新的转变正在拓展消费群体,并促进产品差异化。
与製药公司的竞争
由于处方药和非处方药能够快速缓解症状,因此是治疗急性疾病的首选。对于严重的胃肠道疾病,医疗专业人员可能更倾向于使用经临床验证的药物,而非机能性食品。胃肠道药物的不断进步正在巩固药品在治疗领域的主导地位。许多地区的保险覆盖范围和报销制度也更倾向于药品,从而限制了膳食补充剂的渗透。这限制了益生菌食品在临床胃肠道护理领域的普及。因此,来自药品的竞争仍是市场成长的一大威胁。
新冠疫情加速了消费者对免疫力和肠道健康的关注,对消化健康食品和益生菌快速消费品市场产生了积极影响。封锁措施提高了人们对肠道微生物群在整体健康和疾病抵抗力方面所起作用的认识。疫情期间,益生菌食品、补充品和强化饮料的需求激增。然而,供应链中断最初影响了原料采购和产品分销。随着实体零售受到限制,电子商务和直接面向消费者的分销管道变得日益重要。即使在疫情结束后,市场仍将继续受益于预防性健康消费的持续趋势。
预计在预测期内,益生菌食品和饮料领域将占据最大的市场份额。
由于消费者广泛接受,益生菌食品饮料领域预计将在预测期内占据最大的市场份额。这些产品以优格、发酵饮料、功能性果汁、营养棒等形式融入日常饮食中。经常食用益生菌产品有助于维持肠道平衡、促进消化功能和增强免疫力,因此被视为预防措施。强大的品牌知名度和广泛的零售分销网络进一步推动了该领域的成长。口味、配方和功能方面的持续产品创新吸引了各个年龄层消费者的注意。食品级益生菌因其便利性和熟悉度而促进了重复购买。
预计在预测期内,后生元细分市场将呈现最高的复合年增长率。
由于科学证据的进步和产品稳定性优势,预计在预测期内,后生元领域将实现最高成长率。与活性益生菌不同,后生元无需担心储存或保存期限问题,即可展现持续的功效。越来越多的研究强调了其抗发炎和免疫调节作用,这进一步激发了商业性的兴趣。製造商正将后生元添加到机能性食品、饮料和膳食补充剂中。其非活性特性也使其更容易获得监管部门的核准。消费者对传统益生菌以外的先进肠道健康解决方案越来越感兴趣。
预计北美地区将在预测期内占据最大的市场份额,这主要得益于消费者对肠道健康和预防性营养的高度关注,从而为市场扩张提供了强劲动力。该地区拥有成熟的功能性食品和饮料产业,以及强大的研发能力。胃肠道疾病和文明病的增加正在推动产品的普及。机能性食品监管政策的明朗化也进一步促进了产品的上市。领先益生菌品牌的强大市场地位正在增强市场渗透率。
预计亚太地区在预测期内将实现最高的复合年增长率,快速的都市化和饮食习惯的改变正推动全部区域对消化健康的关注。中国、印度和东南亚等国家不断壮大的中产阶级人口正在推动功能性营养品的需求。传统发酵食品与现代益生菌技术的融合正在促进市场接受度。人们预防保健意识的提高正在加速消化健康产品的消费。有组织的零售业态和电子商务平台的扩张正在提高产品的可及性。
According to Stratistics MRC, the Global Digestive Health Foods & Probiotic FMCG Market is accounted for $56.09 billion in 2025 and is expected to reach $98.02 billion by 2032 growing at a CAGR of 8.3% during the forecast period. Digestive Health Foods & Probiotic FMCG are consumer goods aimed at improving digestive function and supporting a healthy gut microbiome. They encompass items like probiotics, fermented foods, prebiotic-fortified snacks, and functional drinks that encourage the growth of beneficial intestinal bacteria. Rising health consciousness, the increasing occurrence of digestive issues, and a shift towards preventive wellness solutions fuel market growth. Accessible through supermarkets, pharmacies, and online platforms, these products appeal to individuals looking for natural, scientifically validated ways to enhance digestive health and overall well-being.
Rising gastrointestinal (GI) disorders
Changing dietary habits, high stress levels, sedentary lifestyles, and increased consumption of processed foods are worsening gut-related issues globally. Consumers are increasingly seeking preventive and daily nutrition-based solutions rather than relying solely on curative treatments. Probiotic and digestive health foods are perceived as effective options for restoring gut microbiome balance and improving overall digestive function. Greater awareness of the gut-brain and gut-immunity connection is further strengthening market adoption. Healthcare professionals are also recommending probiotics as complementary support for digestive wellness. This sustained rise in GI health concerns is acting as a major growth catalyst for the market.
Lack of global standardization
Regulatory definitions of probiotics, prebiotics, and postbiotics vary widely across regions, creating compliance complexity for manufacturers. Inconsistent requirements related to strain validation, dosage levels, and health claims limit global product scalability. Companies must navigate different food safety authorities, such as FDA, EFSA, and FSSAI, each with distinct approval processes. Smaller players often struggle to meet scientific substantiation requirements due to limited R&D capabilities. This regulatory fragmentation increases time-to-market and operational costs. As a result, lack of standardization restrains innovation and cross-border market expansion.
Non-dairy & plant-based innovation
Increasing lactose intolerance, vegan lifestyles, and dairy allergies are pushing consumers toward alternative probiotic sources. Manufacturers are innovating with plant-based formats such as fermented juices, cereals, legumes, kombucha, and plant-based yogurts. These products appeal to health-conscious and environmentally aware consumers seeking clean-label solutions. Advances in fermentation technology are improving the stability and efficacy of probiotics in non-dairy matrices. Brands are also leveraging superfoods and functional botanicals to enhance digestive benefits. This shift toward plant-based innovation is expanding consumer reach and product differentiation.
Competition from pharmaceuticals
Prescription drugs and over-the-counter medications often deliver faster symptomatic relief, making them a preferred option for acute conditions. Healthcare professionals may prioritize clinically proven pharmaceuticals over functional foods for severe digestive issues. Continuous advancements in gastroenterology drugs are strengthening pharmaceutical dominance in therapeutic segments. Insurance coverage and reimbursement further favor medicines over nutritional products in many regions. This limits the penetration of probiotic foods in clinical digestive care. Consequently, pharmaceutical competition remains a significant threat to market growth.
The COVID-19 pandemic positively influenced the digestive health foods and probiotic FMCG market by accelerating consumer focus on immunity and gut health. Lockdowns increased awareness of the role of the gut microbiome in overall wellness and disease resistance. Demand surged for probiotic foods, supplements, and fortified beverages during the pandemic period. However, supply chain disruptions affected raw material sourcing and product distribution initially. E-commerce and direct-to-consumer channels gained prominence as physical retail faced restrictions. Post-pandemic, the market continues to benefit from sustained preventive health consumption trends.
The probiotic foods & beverages segment is expected to be the largest during the forecast period
The probiotic foods & beverages segment is expected to account for the largest market share during the forecast period, due to widespread consumer acceptance. These products are integrated into daily diets through formats such as yogurts, fermented drinks, functional juices, and nutrition bars. Regular consumption supports gut balance, digestion, and immunity, making them a preferred preventive solution. Strong brand presence and extensive retail availability further enhance segment growth. Continuous product innovation in flavors, formulations, and functional benefits is attracting diverse age groups. The convenience and familiarity of food-based probiotics drive repeat purchases.
The postbiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the postbiotics segment is predicted to witness the highest growth rate, due to increasing scientific validation and product stability advantages. Unlike live probiotics, postbiotics offer consistent efficacy without concerns related to storage and shelf life. Growing research highlighting their anti-inflammatory and immune-modulating benefits is boosting commercial interest. Manufacturers are incorporating postbiotics into functional foods, beverages, and supplements. Regulatory acceptance is relatively easier due to their non-living nature. Consumers are becoming more aware of advanced gut-health solutions beyond traditional probiotics.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness regarding gut health and preventive nutrition strongly supports market expansion. The region has a well-established functional food and beverage industry with strong R&D capabilities. Rising prevalence of digestive disorders and lifestyle-related health issues is increasing product adoption. Regulatory clarity around functional foods further supports product launches. Strong presence of leading probiotic brands enhances market penetration.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and changing dietary patterns are increasing digestive health concerns across the region. Growing middle-class populations in countries such as China, India, and Southeast Asia are driving demand for functional nutrition. Traditional fermented foods combined with modern probiotic innovations support market acceptance. Rising awareness of preventive healthcare is accelerating consumption of digestive health products. Expansion of organized retail and e-commerce platforms improves product accessibility.
Key players in the market
Some of the key players in Digestive Health Foods & Probiotic FMCG Market include Danone S., DSM-Firm, Nestle S.A, Lifeway Foods, Yakult Honsha, Abbott Laboratories, BioGaia AB, PepsiCo Inc., Probi AB, Cargill Inc., General Mills, GlaxoSmithKline, Arla Foods, Archer Daniels Midland, and Chr. Hansen.
In November 2025, dsm-firmenich announces the launch of The Art of Progress Prize, a new global art award celebrating a new generation of visionary artists. Based on the idea that art has the power to shift perspectives, challenge assumptions and spark fresh ideas, this initiative aims to recognize bold, early-career artists whose work brings together innovation, sensory experience, and the theme of sustainability to inspire progress.
In October 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy. Two leading global food companies, Mars and Cargill, announced they are spurring the development of more than 224MWac of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.